MedTrace Logo

Evaluation of a Training for Healthcare Providers in Supporting Men Experiencing Suicidal Ideation

NCT06810713 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 119

Last updated 2026-04-13

No results posted yet for this study

Summary

The primary objective of this study is to assess how healthcare providers perceive and evaluate the developed e-learning. The findings will inform potential adjustments to enhance the e-learning as needed.

Conditions

Interventions

BEHAVIORAL

Gatekeeper training (e-learning)

This training supplements existing modules for healthcare providers working with individuals experiencing suicidal thoughts (https://sp-reflex.zelfmoord1813.be/e-learning). Specific information on working with men will be added: * Information on suicidality among men and the importance of gender-sensitive care. * Guidance on recognizing signs of suicidality in men and understanding gender differences in suicide-related communication. * Insights into the impact of gender norms and socialization on suicidality and help-seeking behavior in men experiencing suicidal thoughts. * Awareness of providers' own gender biases and the influence of societal gender norms in treating men with suicidal ideation. * Recommendations for engaging men in treatment, with specific guidance on language and approaches for interacting with men who have suicidal thoughts. Additionally, the e-learning will a model psychoeducation about the role of norms for men experiencing suicidal ideation.

Sponsors & Collaborators

  • University Ghent

    lead OTHER

Principal Investigators

  • Gwendolyn Portzky, PhD · University Ghent

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-27
Primary Completion
2025-07-13
Completion
2025-07-13

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06810713 on ClinicalTrials.gov